The Science of what's Vital

A world-

leading Medical Research University by 2030

rus

A world-leading Medical Research University by 2030

The Science of what's Vital
rus
are to bring Russian academia — from education, fundamental and applied research to biomedical industrial production — up to a globally competitive level
The University’s strategic aims

Where we’re going

The University’s strategic aims are to bring Russian academia — from education, fundamental and applied research to biomedical industrial production — up to a globally competitive level

Where we’re going

What we’re changing

is aimed toward creating world-beating models for a medical research university that are unique to the Russian environment
Sechenov University’s Programme 2030
Sechenov University’s Programme 2030 is aimed toward creating world-beating models for a medical research university that are unique to the Russian environment

What we’re changing

By 2030 The University shall

to those of world leaders. R&D, training and clinical practise will be brought up to international standards
quality
Improve
standards up
Institute a full entry into the international market
for R&D and high-tech medical services, holding a secure place in aspects of this economic sector
at global levels of their profession
fundamentally new type of graduate,
Will become
professionals who are able to take up fundamentally new forms of research and practise
Prepare
in demand
both at local and international levels, at facilities for both treatment and research
physician-researchers
the future
professionals who are able to take up fundamentally new forms of research and practise
Will be able to shape
Our graduates
Transfer to a new model of medical treatment among the ranks of other research university medical centres
In the Top 50 of general global rankings
Create a model of education where the scientific method encompasses every levels of preparation
Sechenov University will serve science as part of our social environment: it will be a place governed by a scientific worldview
Transform from a specialist to
a multidisciplinary institution of higher learning
This shall involve researchers of all different professional profiles: mathematicians, chemists, physicists, IT-specialists

The University has founded a research centre in the field of non-medical research comparable in concept to those of multidisciplinary universities
breakthrough science, modern educational methods, and technology to improve the well-being of humankind

Why we’re changing

Sechenov University’s mission is to integrate
Sechenov University’s mission is to integrate breakthrough science, modern educational methods, and technology to improve the well-being of humankind

Why we’re changing

2030
2020
Target Model
2020
2030
R&D share in the consolidated budget
21%
5,2%
R&D volume
8,5 RUB bln
1,1 RUB bln
Consolidated budget
40,5 RUB bln
21, 4 RUB bln
In the top 3 of Russian universities
To Russian and international biomedical and pharmaceutical companies, the world’s leading medical research centres and universities as well as national and supranational regulators
Attractive partner
2020
2030
Volume of revenues from clinical practice
18 RUB bln
7,66 RUB bln
In the export of high-tech medical services among former Soviet states
Leader
2020
2030
Volume of R&D performed for Russian and international companies
6,8 RUB bln
0,62 RUB bln
Number of WoS-indexed publications in Q1 and Q2 per year
2850 (480,00*)
1316 (233,2*)
* Calculated using the fractional counting method
Of universities by the volume of translational biomedical research in former Soviet and Eastern European states
In the Top 5
2020
2030
Number of PhD students
1100
523
Share of academic staff under 39
40%
25%
Number of research staff
500
110
Of universities to attract academic staff specialised in biomedicine and postgraduate students to study biomedicine in former Soviet and Eastern European states
In the Top 5
Top 3
2030
status
Budget
Partner
2030
status
Positioning
Leader
2030
status
Revenue
Top 5
2030
status
R&D
Top 5
2030
status
Human Capital
2030
2020
Target Model
2020
2030
R&D share in the consolidated budget
21%
5,2%
R&D volume
8,5 RUB bln
1,1 RUB bln
Consolidated budget
40,5 RUB bln
21, 4 RUB bln
In the Top 3 of Russian universities
To Russian and international biomedical and pharmaceutical companies, the world’s leading medical research centres and universities as well as national and supranational regulators
Attractive partner
2020
2030
Volume of revenues from clinical practice
18 RUB bln
7,66 RUB bln
In the export of high-tech medical services among former Soviet states
Leader
2020
2030
Volume of R&D performed for Russian and international companies
6,8 RUB bln
0,62 RUB bln
Number of WoS-indexed publications in Q1 and Q2 per year
2850 (480,00*)
1316 (233,2*)
* Calculated using the fractional counting method
Of universities by the volume of translational biomedical research in former Soviet and Eastern European states
In the Top-5
2020
2030
Number of PhD students
1100
523
Share of academic staff under 39
40%
25%
Number of research staff
500
110
Of universities to attract academic staff specialised in biomedicine and postgraduate students to study biomedicine in former Soviet and Eastern European states
In the Top-5
Top-3
2030
status
Budget
Partner
2030
status
Positioning
Leader
2030
status
Revenue
Top-5
2030
status
R&D
Top-5
2030
status
Human Capital
2030
2020
Target Model
2030
2020
21%
5,2%
R&D share in the consolidated budget
8,5 RUB bln
1,1 RUB bln
R&D volume
40,5 RUB bln
21, 4 RUB bln
Consolidated budget
In the Top 3 of Russian universities
To Russian and international biomedical and pharmaceutical companies, the world’s leading medical research centres and universities as well as national and supranational regulators
Attractive partner
18 RUB bln
7,66 RUB bln
Volume of revenues from clinical practice
In the export of high-tech medical services among former Soviet states
Leader
2030
2020
6,8 RUB bln
0,62 RUB bln
Volume of R&D performed for Russian and international companies
2850 (480,00*)
1316 (233,2*)
Number of WoS-indexed publications in Q1 and Q2 per year
* Calculated using the fractional counting method
Of universities by the volume of translational biomedical research in former Soviet and Eastern European states
In the Top 5
2030
2020
1100
523
Number of PhD students
40%
25%
Share of academic staff under 39
500
110
Number of research staff
Of universities to attract academic staff specialised in biomedicine and postgraduate students to study biomedicine in former Soviet and Eastern European states
In the Top 5
Human Capital
R&D
Revenue
Budget
Positioning
Target Model
2020
2030
2030
2020
21%
5,2%
R&D share in the consolidated budget
8,5 RUB bln
1,1 RUB bln
R&D volume
40,5 RUB bln
21, 4 RUB bln
Consolidated budget
In the Top 3 of Russian universities
To Russian and international biomedical and pharmaceutical companies, the world’s leading medical research centres and universities as well as national and supranational regulators
Attractive partner
801—900
position in ARWU
position in newsweek world's best hospital
601—700
101—200
2020
2030
18 RUB bln
7,66 RUB bln
Volume of revenues from clinical practice
In the export of high-tech medical services among former Soviet states
Leader
2030
2020
6,8 RUB bln
0,62 RUB bln
Volume of R&D performed for Russian and international companies
2850 (480,00*)
1316 (233,2*)
Number of WoS-indexed publications in Q1 and Q2 per year
* calculated using the fractional counting method
Of universities by the volume of translational biomedical research in former Soviet and Eastern European states
In the Top 5
2030
2020
1100
523
Number of PhD students
40%
25%
Share of academic staff under 39
500
110
Number of research staff
Of universities to attract academic staff specialised in biomedicine and postgraduate students to study biomedicine in former Soviet and Eastern European states
In the Top 5
Human Capital
R&D
Revenue
Budget
Positioning